Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FUSN - Fusion Pharmaceuticals Inc.


IEX Last Trade
21.555
21.555   100.000%

Share volume: 0
Last Updated: Mon 03 Jun 2024 08:15:20 PM CEST
Biological Product (except Diagnostic) Manufacturing : -4.32%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Report Date 2022-05-10 2022-08-09 2022-11-08 2023-03-16 2023-05-11 2023-08-08 2023-11-07
Total revenue 585.000 K 570.000 K 166.000 K 140.000 K 28.000 K 34.000 K 2.006 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 585.000 K 570.000 K 166.000 K 140.000 K 28.000 K 34.000 K 2.006 M
    -2.56% -70.88% -15.66% -80.00% 21.43% 5,800.00%  
Operating expenses 21.110 M 19.857 M 23.971 M 24.557 M 24.883 M 26.747 M 21.395 M
Selling general and admin 8.449 M 7.781 M 7.420 M 6.950 M 9.006 M 7.753 M 6.810 M
Research and development 12.661 M 12.076 M 16.551 M 17.607 M 15.877 M 18.994 M 14.585 M
Total expenses 21.110 M 19.857 M 23.971 M 24.557 M 24.883 M 26.747 M 21.395 M
    -5.94% 20.72% 2.44% 1.33% 7.49% -20.01%  
Operating income -20.525 M -19.287 M -23.805 M -24.417 M -24.855 M -26.713 M -19.389 M
Ebit -20.525 M -19.287 M -23.805 M -24.417 M -24.855 M -26.713 M -19.389 M
Pretax income -19.964 M -19.754 M -24.774 M -24.957 M -24.302 M -25.420 M -17.505 M
    -1.05% 25.41% 0.74% -2.62% 4.60% -31.14%  
Income tax -55.000 K -681.000 K -761.000 K -340.000 K -11.000 K -245.000 K -253.000 K
Net income basic -19.909 M -19.073 M -24.013 M -24.617 M -24.291 M -25.175 M -17.252 M
    4.20% -25.90% -2.52% 1.32% -3.64% 31.47%  
Net income -19.909 M -19.073 M -24.013 M -24.617 M -24.291 M -25.175 M -17.252 M
    4.20% -25.90% -2.52% 1.32% -3.64% 31.47%